2022 update
Josef S Smolen(Medical University of Vienna), Josef S. Smolen, Katerina Chatzidionysiou(Karolinska Institutet), Andrea Rubbert‐Roth(University of Zurich), Axel Finckh(University Hospital of Geneva), Gyula Poór(Semmelweis University), Elsa van Duuren(Sefako Makgatho Health Sciences University), Myrna Cardiel(Universidad de Morelia), Anja Strangfeld(German Rheumatism Research Centre), Felice Rivellese(Queen Mary University of London), Maya H Buch(Arthritis UK), Joan M. Bathon(Columbia University Irving Medical Center), João Eurico Fonseca(University of Lisbon), Khadija El Aoufy(University of Florence), Annamaria Iagnocco(University of Turin), Gorica Ristić(Military Medical Academy), Frank Buttgereit(German Rheumatism Research Centre), Andreas Kerschbaumer(Senatsverwaltung für Stadtentwicklung und Wohnen), Sytske Anne Bergstra(Leiden University Medical Center), Hendrik Schulze‐Koops(LMU Klinikum), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Tsutomu Takeuchi(Keio University), Kim Lauper(University of Geneva), Jacques Éric Gottenberg(Inserm), Savia de Souza(King's College London), R. Westhovens, Catalin Codreanu(Hospital Universitario La Paz), Alfons A. den Broeder(Charles University), Theodora P. M. Vliet Vlieland, Tanja A. Stamm(University of Leeds), Alexandre Sepriano(University of Leeds), Nikolay Stoilov, Daniel Aletaha(Délégation Paris 5), Alejandro Balsa(Humboldt-Universität zu Berlin), Kimme L. Hyrich(University of Leeds), Patrick Verschueren(Leiden University Medical Center), Janet E. Pope(Klinik Hietzing), Roberto Caporali(Maastricht University Medical Centre), Kevin L. Winthrop(University Medical Center Utrecht), Iain B. McInnes(German Rheumatism Research Centre), Peter Nash, Zhanguo Li(Tufts University), Désirée Van Der Heijde, Gerd R. Burmester(University Hospital of Geneva), Espen A. Haavardsholm(Sapienza University of Rome), Maurizio Cutolo(University of Glasgow), Robert Landewé(Zuyderland Medisch Centrum), Annette Van Der Helm-Van Mil, Eduardo Mysler
Cited by 1,628
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
|New England Journal of Medicine|2000|1.8k
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes
|Arthritis & Rheumatism|2002|733